Page 5 - Indian (NIFTY) Pharmaceuticals & Biotech Dividend Stocks

UPDATED Apr 25, 2024

Discover Indian Pharmaceuticals & Biotech High Yield Dividend Stocks that are on the NIFTY and sorted by Dividend Yield. An upper limit of 20% is in place to filter out stocks with potentially unsustainable dividends. All companies with high dividend yields (above 5%) should be researched for sustainability. For more options please click on ‘Advanced Filters’.

112 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

CONCORDBIO

Concord Biotech
₹1,636.403.3%n/a₹171.2b₹1,596.80PE56.2xE23.8%0%

ACCENTMIC

Accent Microcell
₹268.001.4%n/a₹5.6bn/aPE43.3xn/a0%

DCAL

Dishman Carbogen Amcis
₹233.406.3%65.3%₹36.6bn/aPS1.4xn/a0%

524412

Aarey Drugs & Pharmaceuticals
₹53.4513.7%94.6%₹1.5bn/aPE51.9xn/a0%

512529

Sequent Scientific
₹124.804.5%68.9%₹31.0bn/aPS2.3xn/a0%

524500

Kilitch Drugs (India)
₹351.05-0.03%101.9%₹5.6bn/aPE38.7xn/a0%

539287

Ortin Laboratories
₹19.731.5%2.0%₹160.4mn/aPS4.7xn/a0%

BROOKS

Brooks Laboratories
₹106.856.9%68.0%₹2.8bn/aPS3.8xn/a0%

506919

Makers Laboratories
₹145.905.8%33.5%₹860.9mn/aPB1.3xn/a0%

539997

Kwality Pharmaceuticals
₹500.2011.4%33.1%₹5.2bn/aPE43.4xn/a0%

532637

Mangalam Drugs & Organics
₹100.751.3%-12.0%₹1.6bn/aPB1.2xn/a0%

524506

Coral Laboratories
₹383.653.1%47.0%₹1.4bn/aPE15xn/a0%

526953

Venus Remedies
₹327.85-2.0%63.4%₹4.4bn/aPE15.1xn/a0%

SOLARA

Solara Active Pharma Sciences
₹560.8018.4%56.9%₹20.2b₹350.00PS1.4xE111.0%0%

524470

Syncom Formulations (India)
₹13.788.6%123.3%₹13.0bn/aPE49.1xn/a0%

WOCKPHARMA

Wockhardt
₹570.65-0.4%240.8%₹87.5bn/aPS3.2xn/a0%
Page 5 of 5
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.